The U.S. Food and Drug Administration (FDA) is seeking feedback on the benefits and risks of implementing autonomous and remotely operated medical devices in healthcare and has published a paper – Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities – to start a discussion.

Read the full article at HIPAA Journal →